The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

Patients were scored for severity of hayfever symptoms and nasal obstruction ... 2 days for antihistamines (e.g. cetirizine, fexofenadine and ebastine); 2 days for decongestants; 14 days for ...

They will help control the symptoms. These include a runny nose, nasal itching and sneezing. The key to control is to give allergy meds every day during pollen season. Long-acting allergy medicines ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...